Enfortumab Vedotin vs Tirzepatide

Enfortumab Vedotin vs Tirzepatide: Overview

This comparison examines the pharmacological differences between Enfortumab Vedotin and Tirzepatide.

Mechanism of Action

Tirzepatide: Dual GIP and GLP-1 receptor agonist.

Pharmacokinetics

Half-life: Tirzepatide — 5 days.

Chemical Properties

Type: Enfortumab Vedotin — Antibody drug conjugate; Tirzepatide — Protein.